Theravance Biopharma Inc. (TBPH) shares plunged 28% in pre-market trading after the company announced that its hypertension drug failed to meet the primary endpoint in a pivotal late-stage clinical trial.

Theravance Biopharma Inc. (TBPH) shares plunged 28% in pre-market trading after the company announced that its hypertension drug failed to meet the primary endpoint in a pivotal late-stage clinical trial.

老虎证券2026/03/03 14:06

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

This disappointing trial result directly triggered a significant sell-off in the market. As the drug failed to achieve the preset efficacy endpoint, the company announced it would immediately conduct a comprehensive evaluation of the development project for this hypertension medication and plans to initiate a strategic review of the company’s overall pipeline. The purpose of this strategic assessment is to reallocate R&D resources and evaluate future development paths.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Microsoft has announced a major upgrade to Copilot: Word, Excel and PowerPoint will be directly integrated into this AI assistant. Additionally, new programming tool Code and a continuously running AI agent called Autopilot have been introduced, aiming to transform Copilot from a single AI assistant into a one-stop solution for office work, programming, and task execution.

华尔街见闻•2026/09/26 00:41

The United States requires Colorado coal-fired power plants to remain operational

智通财经•2026/09/25 23:46

Warner Bros. Discovery plans to delist euro-denominated notes from Nasdaq.

智通财经•2026/09/25 22:46